Related references
Note: Only part of the references are listed.A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease
Han-Yun Hsiao et al.
HUMAN MOLECULAR GENETICS (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
Wolfgang Brueck et al.
ACTA NEUROPATHOLOGICA (2012)
TR-FRET-Based Duplex Immunoassay Reveals an Inverse Correlation of Soluble and Aggregated Mutant huntingtin in Huntington's Disease
Barbara Baldo et al.
CHEMISTRY & BIOLOGY (2012)
NF-κB, the first quarter-century: remarkable progress and outstanding questions
Matthew S. Hayden et al.
GENES & DEVELOPMENT (2012)
Mutant huntingtin impairs immune cell migration in Huntington disease
Wanda Kwan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression
Andreas Weiss et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease
Wanda Kwan et al.
JOURNAL OF NEUROSCIENCE (2012)
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease
Jill Bouchard et al.
JOURNAL OF NEUROSCIENCE (2012)
P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease
Jing Fan et al.
NEUROBIOLOGY OF DISEASE (2012)
Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
Giancarlo Comi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cytokine release from innate immune cells: association with diverse membrane trafficking pathways
Paige Lacy et al.
BLOOD (2011)
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Daniel Zwilling et al.
CELL (2011)
Nuclear initiated NF-kappa B signaling: NEMO and ATM take center stage
Shigeki Miyamoto
CELL RESEARCH (2011)
Quantifying Nuclear p65 as a Parameter for NF-κB Activation: Correlation Between ImageStream Cytometry, Microscopy, and Western Blot
Orla Maguire et al.
CYTOMETRY PART A (2011)
Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease
Lise Munsie et al.
HUMAN MOLECULAR GENETICS (2011)
Oligonucleotide therapeutic approaches for Huntington disease
Dinah W. Y. Sah et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The role of immunity in Huntington's disease
D. Soulet et al.
MOLECULAR PSYCHIATRY (2011)
The role of IκB kinase complex in the neurobiology of Huntington's disease
Ali Khoshnan et al.
NEUROBIOLOGY OF DISEASE (2011)
NF-κΒ Signaling in Neurite Growth and Neuronal Survival
Felicia Yu Hsuan Teng et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Does Huntingtin play a role in selective macroautophagy?
Joan S. Steffan
CELL CYCLE (2010)
TNF-α, IL-6, and IL-1 expression is inhibited by GAS6 in monocytes/macrophages
Federica Alciato et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Microglial Physiology: Unique Stimuli, Specialized Responses
Richard M. Ransohoff et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Implication of the JNK pathway in a rat model of Huntington's disease
V. Perrin et al.
EXPERIMENTAL NEUROLOGY (2009)
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
Leslie Michels Thompson et al.
JOURNAL OF CELL BIOLOGY (2009)
Beyond the brain: widespread pathology in Huntington's disease
Jorien M. M. van der Burg et al.
LANCET NEUROLOGY (2009)
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Myriam Aouadi et al.
NATURE (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
Maria Bjorkqvist et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner
Caroline L. Benn et al.
JOURNAL OF NEUROSCIENCE (2008)
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Bahareh Ajami et al.
NATURE NEUROSCIENCE (2007)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion
Mohanraj Rajesh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates
Annette Dalrymple et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Roles for NF-κB in nerve cell survival, plasticity, and disease
MP Mattson et al.
CELL DEATH AND DIFFERENTIATION (2006)
Regional and cellular gene expression changes in human Huntington's disease brain
A Hodges et al.
HUMAN MOLECULAR GENETICS (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Real-time imaging of ligand-induced IKK activation in intact cells and in living mice
S Gross et al.
NATURE METHODS (2005)
Akt is altered in an animal model of Huntington's disease and in patients
E Colin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Activation of the IκB kinase complex and nuclear factor-κB contributes to mutant Huntingtin neurotoxicity
A Khoshnan et al.
JOURNAL OF NEUROSCIENCE (2004)
Functions of NF-κB1 and NF-κB2 in immune cell biology
S Beinke et al.
BIOCHEMICAL JOURNAL (2004)
Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules
LR Gauthier et al.
CELL (2004)
Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
FC Nucifora et al.
SCIENCE (2001)
Early and progressive accumulation of reactive microglia in the Huntington disease brain
E Sapp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The IKK complex:: an integrator of all signals that activate NF-κB?
A Israël
TRENDS IN CELL BIOLOGY (2000)
Share Paper
